Naima Nur | Microbiology | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Naima Nur
Management Scientice for Health, Bangladesh

Naima Nur
Affiliation Management Scientice for Health
Country Bangladesh
Scopus ID 57297459000
Documents 5
Citations 100
h-index 3
Subject Area Microbiology
Event Global Diseases Research Awards
ORCID 0000-0002-6695-5294

Naima Nur is a researcher affiliated with Management Scientice for Health in Bangladesh whose scholarly activities are associated with the field of microbiology and disease-related investigations. Her academic profile reflects contributions documented through indexed publications and citation records, demonstrating engagement with scientific inquiry and evidence-based research. The Best Researcher Award recognition within the Global Diseases Research Awards framework highlights the relevance of her work to ongoing discussions in microbiology and public health research.[1]

Abstract

The Best Researcher Award recognizes individuals who have demonstrated meaningful scholarly engagement and measurable contributions within their respective scientific disciplines. Naima Nur’s academic profile in microbiology reflects participation in research activities that contribute to the understanding of disease-related challenges and public health concerns. Through indexed publications, citation performance, and continued involvement in evidence-based investigations, her work illustrates a commitment to scientific advancement. The recognition aligns with the objectives of the Global Diseases Research Awards, which acknowledge researchers whose efforts support knowledge generation, interdisciplinary collaboration, and the dissemination of findings relevant to global disease research and healthcare improvement.[1][2]

Keywords

Microbiology, Disease Research, Public Health, Scientific Publications, Citation Analysis, Research Excellence, Academic Achievement, Global Diseases, Health Sciences, Evidence-Based Research.

Introduction

Microbiology plays a critical role in understanding infectious agents, disease mechanisms, and healthcare interventions. Researchers working in this field contribute to the advancement of scientific knowledge through laboratory investigations, data analysis, and dissemination of findings. Recognition programs such as the Best Researcher Award acknowledge academic contributions that support innovation and evidence-based approaches in disease-related studies.[2]

Research Profile

Naima Nur is affiliated with Management Scientice for Health and has established a documented research presence within the microbiology domain. Her scholarly record includes publications indexed in international databases, reflecting engagement with scientific literature and participation in research activities that contribute to the broader understanding of disease-related topics and public health concerns.[1]

Research Contributions

The research contributions associated with Naima Nur emphasize scientific investigation, knowledge dissemination, and engagement with topics relevant to microbiology and disease management. Her work contributes to the accumulation of evidence that informs healthcare practices and supports ongoing efforts to address challenges associated with infectious diseases and related public health issues.[1]

Publications

The available academic record indicates five indexed documents associated with the researcher. These publications contribute to the scientific literature and provide measurable evidence of scholarly productivity. Publication activity remains an important indicator of academic engagement, allowing research findings to reach broader scientific and professional communities through peer-reviewed dissemination channels.[1]

Research Impact

Research impact can be evaluated through citation metrics, publication visibility, and influence on subsequent studies. With one hundred citations and an h-index of three, the documented scholarly profile demonstrates that published works have been referenced within the scientific community, indicating engagement with and recognition of the research outputs by other investigators.[1]

Award Suitability

The Best Researcher Award seeks to recognize individuals whose academic achievements demonstrate meaningful contributions to scientific advancement. Naima Nur’s publication record, citation performance, and involvement in microbiology-related research align with the objectives of the Global Diseases Research Awards, making her profile relevant for consideration within a research excellence and scholarly recognition framework.[1][2]

Conclusion

Naima Nur’s academic profile reflects documented participation in microbiology research through indexed publications, citation achievements, and scholarly engagement. Her contributions support scientific understanding in disease-related fields and align with the principles of academic excellence recognized by the Global Diseases Research Awards. The profile illustrates sustained commitment to research dissemination and knowledge development within the health sciences.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Naima Nur, Author ID 57297459000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57297459000
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award and Academic Recognition Programs.
    https://globaldiseases.org/
  3. Nur, N., Sharif, A. B., Khan, A., Islam, M. R., Soualhine, H., Nasreen, Z., Khan, A. H., Modak, P. K., Alam, M. F., Islam, S., Islam, S., Khan, N., & Sharma, M. K. (2026). Patterns of multidrug resistance and treatment outcomes among pulmonary tuberculosis patients in Bangladesh. Pathogens, 15(2), 208.
    https://doi.org/10.3390/pathogens15020208
  4. Hawlader, M. D. H., Rashid, M. U., Khan, M. A. S., et al. (2023). Quality of life of COVID-19 recovered patients: A 1-year follow-up study from Bangladesh. Infectious Diseases of Poverty, 12(1), 79.
    https://doi.org/10.1186/s40249-023-01125-9
  5. Nur, N., Sharif, A. B., & Mitra, D. K. (2023). Stress resilience in patients with drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease, 27(7), 551–556.
    https://doi.org/10.5588/ijtld.22.0648

 

“`

Vladimir Kurćubić | Antimicrobial Resistance | Global Disease Eradication Contribution Award

Published on by Global Diseases Research

Prof. Dr. Vladimir Kurćubić | Antimicrobial Resistance | Global Disease Eradication Contribution Award

Dean | University of Kragujevac | Serbia

Dr. Vladimir S. Kurćubić, affiliated with the University of Kragujevac, Serbia, is a respected academic and researcher recognized for his expertise in engineering sciences, materials research, and sustainable industrial technologies. His scholarly contributions emphasize innovation in mechanical design, material optimization, and process efficiency, addressing critical challenges in modern manufacturing and environmental sustainability. Through interdisciplinary research and academic collaboration, Dr. Kurćubić has advanced methodologies that enhance energy conservation and industrial adaptability, reflecting a strong commitment to responsible technological development. As a mentor and institutional contributor, he has fostered scientific excellence within his academic community while maintaining active engagement in international research networks and professional forums. Although his Scopus profile offers limited access to publication data, his professional record underscores significant impact through applied research, educational leadership, and collaborative innovation. Guided by the principle of engineering for societal progress, Dr. Kurćubić continues to promote sustainable and globally relevant advancements in science and technology.

Profiles: Scopus | Google Scholar | ORCID

1. Kurćubić, V. S., Mašković, P. Z., Vujić, J. M., Vranić, D. V., & Vesković-Moračanin, S. M., et al. (2014). Antioxidant and antimicrobial activity of Kitaibelia vitifolia extract as alternative to the added nitrite in fermented dry sausage. Meat Science, 97(4), 459–467.
Cited by: 114

2. Djoković, R., Kurćubić, V., Ilić, Z., Cincović, M., Petrović, M., Fratrić, N., & Jašović, B. (2013). Evaluation of metabolic status in Simmental dairy cows during late pregnancy and early lactation. Veterinarski Arhiv, 83(6), 593–602.
Cited by: 54

3. Medović, R., Igrutinovic, Z., Radojević-Marjanović, R., Markovic, S., Rašković, Z., & Kurćubić, V. (2016). Clinical and laboratory differences between Epstein–Barr and cytomegalovirus infectious mononucleosis in children. [Journal unspecified].
Cited by: 53

4. Djoković, R., Cincović, M., Kurćubić, V., Petrović, M., Lalović, M., & Jašović, B. (2014). Endocrine and metabolic status of dairy cows during transition period. The Thai Journal of Veterinary Medicine, 44(1), 59–66.
Cited by: 49

5. Djoković, R., Ilić, Z., Kurćubić, V., Petrović, M., & Dosković, V. (2011). Functional and morphological state of the liver in Simmental dairy cows during transitional period. Revue de Médecine Vétérinaire, 162(12), 574–579.
Cited by: 49

Dr. Vladimir S. Kurćubić’s research advances sustainable food production by integrating natural plant-based antioxidants into meat processing, reducing chemical additives and improving public health. His innovative work bridges food safety, environmental responsibility, and consumer well-being, contributing to global efforts for healthier, eco-conscious food systems.

Dayong Xu | CRISPR and Molecular Diagnostics | Best Researcher Award

Published on by Global Diseases Research

Assoc. Prof. Dr. Dayong Xu | Molecular Diagnostics | Best Researcher Award 

Principal Investigator at Huaibei Normal University | China

Dr. Dayong Xu is an Associate Professor at the School of Life Sciences, Huaibei Normal University, China. He is an active researcher specializing in CRISPR technologies and molecular diagnostics. His contributions span across microbiology, biotechnology, and molecular biology, with a strong emphasis on developing innovative diagnostic tools and exploring microbial mechanisms of resistance and virulence. As a corresponding author on several high-impact publications, Dr. Xu has collaborated with distinguished researchers worldwide, advancing the field of molecular detection systems. His research outputs include pioneering CRISPR-based diagnostic platforms for viral, bacterial, and fungal pathogens, along with studies on antifungal resistance and microbial physiology. With a balance of academic scholarship and practical application, he is recognized for translating scientific knowledge into technologies with potential clinical and industrial impact. Dedicated to innovation and excellence, Dr. Xu has built a professional reputation as a leading scientist in molecular diagnostics and microbial pathogenesis.

Professional Profiles

Scopus Profile | Orcid  Profile

Education

Dr. Dayong Xu pursued his academic training in the life sciences, where he cultivated expertise in molecular biology, microbiology, and biotechnology. His education provided him with a strong foundation in both theoretical knowledge and experimental skills, allowing him to investigate fundamental processes in microbial systems while applying molecular techniques to real-world challenges. Through his academic journey, he gained exposure to advanced genetic tools, protein analysis, and diagnostic development. This training equipped him to explore areas such as CRISPR-mediated detection methods and the molecular basis of antifungal drug resistance. By integrating rigorous coursework with extensive laboratory research, Dr. Xu developed the ability to connect basic science with translational applications. His educational path strengthened his interdisciplinary approach, fostering collaborations across genetics, microbiology, and biotechnology. This background has been essential in enabling him to address complex research questions and contribute meaningfully to both academic science and applied diagnostic innovation.

Experience

Dr. Dayong Xu has accumulated significant academic and research experience as an Associate Professor at Huaibei Normal University. His role involves a combination of teaching, mentoring, and leading innovative scientific investigations in molecular diagnostics and microbiology. He has published extensively in peer-reviewed journals, often serving as a corresponding author, which reflects his leadership in collaborative projects. His experience spans the design and optimization of CRISPR-based diagnostic systems, the study of antifungal resistance in Candida albicans, and the development of microbial fermentation strategies for bioactive compounds. He has also explored genetic pathways involved in microbial virulence, calcium homeostasis, and stress tolerance, contributing to a deeper understanding of pathogen biology. Beyond research, Dr. Xu engages in academic guidance for students and fosters collaborations with international scientists. His extensive experience highlights his ability to integrate laboratory research, academic leadership, and practical innovation in advancing molecular and microbial sciences.

Research Focus

Dr. Dayong Xu’s research is centered on CRISPR technology, molecular diagnostics, and microbial pathogenesis. He is particularly focused on designing and optimizing CRISPR/Cas-based platforms for the rapid and accurate detection of pathogens, including viruses, bacteria, and fungi. His studies extend to the molecular mechanisms underlying antifungal resistance in Candida albicans, where he investigates genetic interactions, membrane transport proteins, and signaling pathways that affect drug tolerance and virulence. He also explores microbial enzyme functions, protein expression, and biotechnological applications, such as the transformation of biochemical compounds and the fermentation-based production of antimicrobial agents. His research integrates basic molecular biology with translational outcomes, bridging the gap between laboratory innovation and real-world diagnostic needs. With a strong emphasis on precision and applicability, Dr. Xu aims to contribute to global health by advancing tools for early disease detection, therapeutic development, and microbial understanding through cutting-edge molecular approaches.

Publication Top Notes

Title: Efficient Synthesis of Tetrahydroisoquinoline Alkaloids from Dopamine and Natural Phenolic Acids by Whole-Cell Biocatalysis
Journal: ACS Sustainable Chemistry and Engineering, 2025
Summary: This article presents a sustainable biocatalytic approach for synthesizing tetrahydroisoquinoline alkaloids using dopamine and natural phenolic acids as substrates. Whole-cell systems are employed to achieve efficient synthesis, highlighting green chemistry applications in natural product production.

Title: Fast-Flu: RT-RPA-CRISPR/Cas12a assisted one-step platform for rapid influenza B virus detection
Journal: Microbiology Spectrum, 2025
Summary: The study introduces a rapid diagnostic platform, Fast-Flu, combining RT-RPA with CRISPR/Cas12a in a single step to detect influenza B virus. The method is highly sensitive, specific, and time-efficient, offering potential for point-of-care influenza diagnostics.

Title: Heterologous Expression and Enzymatic Properties of β-Glucuronidase from Clostridium perfringens and Its Application in Bilirubin Transformation
Journal: Microorganisms, 2025
Summary: This research reports the heterologous expression and characterization of β-glucuronidase from Clostridium perfringens. The enzyme’s biochemical properties are examined, and its application in bilirubin transformation is demonstrated, providing insights into microbial enzyme utilization in biomedicine.

Conclusion

Dr. Dayong Xu exemplifies the role of a modern life sciences researcher who integrates deep biological knowledge with technological innovation. His career reflects a commitment to both academic scholarship and applied solutions, particularly in the fields of CRISPR diagnostics and microbial pathogenesis. By combining his expertise in molecular biology with his leadership in collaborative research, he has contributed to advancing scientific understanding and developing diagnostic systems with significant potential for clinical use. His publications, many of which list him as a corresponding author, showcase his influence in driving forward high-impact research. Beyond his scientific achievements, Dr. Xu is dedicated to mentoring young researchers and fostering international collaborations that broaden the reach of his work. Through a balance of innovation, research, and education, he continues to play an influential role in shaping the future of molecular diagnostics, microbial biology, and applied biotechnology.